GLP-1 medications are not currently included in the Pillcheck Report because there are no clinical guidelines or drug labelling information.
Emerging research has identified several genetic markers linked to weight-loss rates and nausea risk with GLP-1s. These findings are promising, but they're still new and haven't been turned into clinical guidelines yet. They also don't yet tell us anything about the rarer, more serious side effects of GLP-1 medications, such as pancreatitis, thyroid cancer, or vision changes. Once clinical guidelines for GLP-1 drugs are published, Pillcheck will add reporting for them.
In the meantime, if you are considering a GLP-1 medication, our clinical pharmacists, who are trained in pharmacogenetics, can include it in their review of your full medication list. They can flag potential interactions with your other medications and explain what current research does and doesn't tell us. Always talk to your doctor or pharmacist before starting, stopping, or changing any medication.
Was this article helpful?
That’s Great!
Thank you for your feedback
Sorry! We couldn't be helpful
Thank you for your feedback
Feedback sent
We appreciate your effort and will try to fix the article